Triple-negative breast cancer (TNBC) is characterized by estrogen receptor-negativity (ER-), progesterone receptor-negativity (PR-) and human epidermal growth factor receptor 2-negativity (HER2-negative). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.